Scientists who work in mycology — the study of fungi — say there is precious little money available to study Candida auris, according to an article on the STAT News website.
Candida auris is making news for its ability to resist multiple antifungal drugs and settle into hospital rooms so persistently it can take renovations to get rid of it.
The head of mycotic diseases at the Centers for Disease Control and Prevention (CDC) acknowledged his field hasn’t attracted the same kind of research dollars as other pathogens.
A high proportion of people who have been diagnosed with C. auris have died — the CDC estimates it’s between 30 percent and 60 percent.
The Role of Biophilic Design in Healthcare Facilities
TriStar Centennial Medical Center Invests $90M in Women, Children's Hospital Expansions
Virginia Cancer Specialists to Open Newly Expanded Fauquier Location
Emergency Preparedness: Building a Stronger Community
Ground Broken on Lavine Bekenstein Cancer Hospital in Massachusetts